Teva moves anti-IL-15 antibody to Phase 2b for vitiligo treatment

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 10 hours ago

Apple’s Tim Cook sees Australia’s social media curbs as ’world-leading’, PM says

Investing.com

stocksabout 12 hours ago

Venezuela leader Rodriguez signs agreement with French Oil Company Total Energies

Investing.com

stocksabout 14 hours ago

AI safety efforts will require more compute, not less: experts

Investing.com